Table 6.

Treatment-related adverse events (AEs) occurring in the safety population

	Besifloxacin 0.6% N = 37	Moxifloxacin 0.5% N = 36	Gatifloxacin 0.3% N = 36	Total N = 109
Ocular pain	3 (8.1%)	1 (2.8%)	1 (2.8%)	5 (4.6%)
Foreign body sensation	0 (0.0%)	0 (0.0%)	1 (2.8%)	1 (0.9%)
Blurred vision	1 (2.7%)	0 (0.0%)	0 (0.0%)	1 (0.9%)
Dysgeusia	0 (0.0%)	1 (2.8%)	0 (0.0%)	1 (0.9%)
Headache	1 (2.7%)	1 (2.8%)	0 (0.0%)	2 (1.8%)
Procedural site reaction	0 (0.0%)	1 (2.8%)	0 (0.0%)	1 (0.9%)

Notes: Includes AEs determined by the investigator to have a possible, probable, or definite relationship to the study medication.